Jane Street
VKTX icon

Jane Street’s Viking Therapeutics VKTX Stock Holding History

Jane Street’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
332,100
+141,000
+74% +$4.55M ﹤0.01% 2555
2026
Q1 		$6.22M Sell
191,100
-55,500
-23% -$1.78M ﹤0.01% 3188
2025
Q4 		$8.68M Sell
246,600
-48,800
-17% -$1.73M ﹤0.01% 2496
2025
Q3 		$7.76M Buy
295,400
+201,800
+216% +$6.02M ﹤0.01% 2761
2025
Q2 		$2.48M Sell
93,600
-58,500
-38% -$1.54M ﹤0.01% 4082
2025
Q1 		$3.67M Sell
152,100
-129,700
-46% -$4.1M ﹤0.01% 3392
2024
Q4 		$11.3M Sell
281,800
-57,000
-17% -$3.25M ﹤0.01% 1764
2024
Q3 		$21.4M Buy
338,800
+142,000
+72% +$8.33M ﹤0.01% 1192
2024
Q2 		$10.4M Sell
196,800
-66,500
-25% -$4.36M ﹤0.01% 2013
2024
Q1 		$21.6M Buy
263,300
+199,900
+315% +$8.89M ﹤0.01% 1128
2023
Q4 		$1.18M Buy
63,400
+30,700
+94% +$401K ﹤0.01% 5270
2023
Q3 		$362K Sell
32,700
-67,900
-67% -$971K ﹤0.01% 6764
2023
Q2 		$1.63M Sell
100,600
-28,800
-22% -$603K ﹤0.01% 4472
2023
Q1 		$2.15M Buy
129,400
+91,800
+244% +$948K ﹤0.01% 3696
2022
Q4 		$353K Buy
+37,600
New +$168K ﹤0.01% 6736
2021
Q3 		– Sell
-21,300
Closed -$128K – 10796
2021
Q2 		$128K Sell
21,300
-22,000
-51% -$131K ﹤0.01% 9149
2021
Q1 		$274K Buy
43,300
+26,500
+158% +$186K ﹤0.01% 7822
2020
Q4 		$95K Buy
16,800
+600
+4% +$3.63K ﹤0.01% 7217
2020
Q3 		$94K Sell
16,200
-1,300
-7% -$8.95K ﹤0.01% 6771
2020
Q2 		$126K Buy
+17,500
New +$116K ﹤0.01% 6625
2018
Q4 		– Sell
-40,100
Closed -$699K – 5777
2018
Q3 		$699K Buy
+40,100
New +$477K ﹤0.01% 3207

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street's VKTX Position: Q2 2026 in Review

Jane Street increased its Viking Therapeutics (VKTX) stake by 20% in Q2 2026, buying an estimated $4.86M and bringing the position to 899,558 shares worth $35.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Jane Street first reported a position in VKTX in Q3 2018 and has held it in 30 quarters since. The position peaked at $52.8M in Q4 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Jane Street held 899,558 shares of Viking Therapeutics worth $35.1M as of Q2 2026.
  • Jane Street bought 150,609 Viking Therapeutics shares in Q2 2026, an estimated $4.86M.
  • Viking Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1667 holding.
  • Jane Street first reported a position in Viking Therapeutics in Q3 2018 and has held it in 30 quarters since.
  • Jane Street's Viking Therapeutics position peaked at $52.8M in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.